No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ASPN240517P35000
- 8.00
- -1.90-19.19%
15min DelayTrading May 10 10:15 ET
8.00High8.00Low
8.00Open9.90Pre Close1 Volume2 Open Interest35.00Strike Price800.00Turnover0.00%IV0.04%PremiumMay 17, 2024Expiry Date8.26Intrinsic Value100Multiplier7DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma3.24Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- 1D
News
Express News | NYSE Order Imbalance 129139.0 Shares on Buy Side
Aspen Aerogels Insider Sold Shares Worth $1,379,527, According to a Recent SEC Filing
Corby C Whitaker, SVP, Sales and Marketing, on May 06, 2024, sold 55,159 shares in Aspen Aerogels (ASPN) for $1,379,527.
Aspen Aerogels Insider Sold Shares Worth $1,228,722, According to a Recent SEC Filing
Gregg Landes, SVP, Operations and Strat Deve, on May 06, 2024, sold 48,386 shares in Aspen Aerogels (ASPN) for $1,228,722.
Aspen Aerogels(ASPN.US) Officer Sells US$1.23 Million in Common Stock
$Aspen Aerogels(ASPN.US)$ Officer Landes Gregg sold 48,386 shares of common stock on May 6, 2024 at an average price of $25.39 for a total value of $1.23 million.Source: Announcement What is statement
Aspen Aerogels(ASPN.US) Officer Sells US$1.38 Million in Common Stock
$Aspen Aerogels(ASPN.US)$ Officer Whitaker Corby C sold 55,159 shares of common stock on May 6, 2024 at an average price of $25.01 for a total value of $1.38 million.Source: Announcement What is state
Aspen Aerogels' (NYSE:ASPN) Stock Surges on EV Market Pivot
Comments
$Aspen Aerogels(ASPN.US$ let's gp
2
Aspen Aerogels' high P/S ratio is backed by strong revenue growth, outpacing the Chemicals industry. Investors' confidence in future revenues supports the high P/S ratio and share price. Yet, the company's prospects shouldn't be judged solely on the P/S ratio.
Aspen Aerogel's high P/S ratio is echoed by strong revenue growth, surpassing industry standard. With impressive growth forecasts exceeding industry estimates, the high P/S ratio is justifiable. The stock's rising trend indicates shareholders foresee continued outperformance, with no sharp drop in share price anticipated soon.
Aspen Aerogels has drawn concerns due to its liabilities and absence of EBIT level profitability despite observing 41% revenue growth. Given the debt usage, its current state appears risky, necessitating close monitoring of balance sheet and understanding the high risks tied to the stock.
Gainers:
• $Exicure(XCUR.US$ stock is rocketing more than 2,313% due to a one-for-30 reverse stock split.
• $Revelation Biosciences(REVB.US$ shares are soaring over 120% alongside heavy trading this morning.
• $Remark Holdings(MARK.US$ stock is surging more than 55% with heavier-than-normal trading this morning.
• $374Water(SCWO.US$ shares are gaining over 54% ahead of its Nasdaq bell ringing tomorrow.
• $Aspen Aerogels(ASPN.US$ ...
• $Exicure(XCUR.US$ stock is rocketing more than 2,313% due to a one-for-30 reverse stock split.
• $Revelation Biosciences(REVB.US$ shares are soaring over 120% alongside heavy trading this morning.
• $Remark Holdings(MARK.US$ stock is surging more than 55% with heavier-than-normal trading this morning.
• $374Water(SCWO.US$ shares are gaining over 54% ahead of its Nasdaq bell ringing tomorrow.
• $Aspen Aerogels(ASPN.US$ ...
17
Read more
102494559 : 冲不破压力位
Tom2808OP 102494559: 慢慢冲。可以的